Wolfram Klapper

49.8k total citations · 3 hit papers
339 papers, 11.4k citations indexed

About

Wolfram Klapper is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Wolfram Klapper has authored 339 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Pathology and Forensic Medicine, 144 papers in Oncology and 70 papers in Genetics. Recurrent topics in Wolfram Klapper's work include Lymphoma Diagnosis and Treatment (237 papers), Viral-associated cancers and disorders (88 papers) and Chronic Lymphocytic Leukemia Research (62 papers). Wolfram Klapper is often cited by papers focused on Lymphoma Diagnosis and Treatment (237 papers), Viral-associated cancers and disorders (88 papers) and Chronic Lymphocytic Leukemia Research (62 papers). Wolfram Klapper collaborates with scholars based in Germany, United States and Switzerland. Wolfram Klapper's co-authors include Reiner Siebert, Ilske Oschlies, Alfred Reiter, Wolfgang Hiddemann, Birgit Burkhardt, Martin Dreyling, Martin‐Leo Hansmann, Andreas Rosenwald, Eva Hoster and Ralf Küppers and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Communications.

In The Last Decade

Wolfram Klapper

327 papers receiving 11.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

2007 621 citations Eva Hoster, Martin Dreyling et al. Blood profile →
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

2017 461 citations Wolfram Klapper et al. profile →
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

2013 372 citations Heike Horn, Marita Ziepert et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Wolfram Klapper	7.0k	5.1k	2.8k	2.6k	1.9k	339	11.4k
Izidore S. Lossos	5.8k 0.8×	4.3k 0.8×	2.5k 0.9×	2.9k 1.1×	2.8k 1.5×	353	10.8k
Eric D. Hsi	6.0k 0.8×	4.7k 0.9×	3.5k 1.2×	3.2k 1.2×	2.6k 1.4×	405	12.2k
Armando López‐Guillermo	8.4k 1.2×	5.2k 1.0×	4.4k 1.6×	1.8k 0.7×	2.4k 1.3×	244	11.5k
Miguel Á. Piris	8.5k 1.2×	6.3k 1.2×	3.9k 1.4×	3.6k 1.4×	2.8k 1.5×	328	14.2k
Yasodha Natkunam	4.5k 0.6×	4.4k 0.9×	1.4k 0.5×	2.3k 0.9×	2.1k 1.1×	238	8.8k
Stephan W. Morris	4.5k 0.6×	3.9k 0.8×	1.4k 0.5×	4.6k 1.8×	2.2k 1.2×	120	12.0k
Giorgio Inghirami	5.9k 0.8×	8.0k 1.6×	3.0k 1.0×	6.1k 2.3×	4.3k 2.3×	268	16.8k
Alessandro M. Gianni	3.1k 0.4×	3.7k 0.7×	3.4k 1.2×	2.1k 0.8×	2.1k 1.1×	205	9.4k
Azra H. Ligon	2.7k 0.4×	4.9k 0.9×	2.2k 0.8×	4.5k 1.7×	2.2k 1.2×	89	11.5k
Jan Delabie	4.7k 0.7×	3.2k 0.6×	1.9k 0.7×	1.4k 0.5×	1.7k 0.9×	201	7.0k

Countries citing papers authored by Wolfram Klapper

Since Specialization

Citations

This map shows the geographic impact of Wolfram Klapper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Klapper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Klapper more than expected).

Fields of papers citing papers by Wolfram Klapper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfram Klapper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Klapper. The network helps show where Wolfram Klapper may publish in the future.

Co-authorship network of co-authors of Wolfram Klapper

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfram Klapper. A scholar is included among the top collaborators of Wolfram Klapper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfram Klapper. Wolfram Klapper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lollies, Anna, M. Schneider, Patricia Johansson, et al.. (2025). Common origin and somatic mutation patterns of composite lymphomas and leukemias. Leukemia. 39(8). 1960–1971.

Kurz, Katrin S., Markus Kreuz, Marita Ziepert, et al.. (2025). Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA. HemaSphere. 9(3). e70093–e70093.

Kobayashi, Ryōji, et al.. (2023). Non‐germinal center B‐cell subtype of pediatric diffuse large B‐cell lymphoma in Japan: A retrospective cohort study. Pediatric Blood & Cancer. 70(5). e30279–e30279.

Hartmann, Sylvia, Stefan Dojcinov, Snježana Dotlić, et al.. (2023). The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(4). 451–463. 4 indexed citations

Au-Yeung, Rex, Laura Padilla, Martin Zimmermann, et al.. (2022). Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma. Leukemia. 37(2). 488–491. 3 indexed citations

Balsas, Patricia, Luis Veloza, Guillem Clot, et al.. (2021). SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma. Blood. 138(22). 2202–2215. 32 indexed citations

Zimmermann, Heiner, Mirko Nitsche, Christiane Pott, et al.. (2021). Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry. Annals of Hematology. 100(8). 2043–2050. 8 indexed citations

Richter, Julia, Katharina John, Annette M. Staiger, et al.. (2021). Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. British Journal of Haematology. 196(3). 681–689. 16 indexed citations

Au-Yeung, Rex, Laura Padilla, Martin Zimmermann, et al.. (2020). Experience with provisional WHO‐entities large B‐cell lymphoma with IRF4‐rearrangement and Burkitt‐like lymphoma with 11q aberration in paediatric patients of the NHL‐BFM group. British Journal of Haematology. 190(5). 753–763. 41 indexed citations

10.

Attarbaschi, Andishe, Oussama Abla, Laura Padilla, et al.. (2020). Rare non‐Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma. Pediatric Blood & Cancer. 67(8). e28416–e28416. 25 indexed citations

11.

Sandmann, Sarah, Stephanie Müller, Marius Wöste, et al.. (2020). Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma. Leukemia. 35(2). 639–643. 13 indexed citations

12.

Michaelsen, Thomas Yssing, Julia Richter, Rasmus Froberg Brøndum, et al.. (2018). A B-cell–associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology. Blood Advances. 2(13). 1542–1546. 7 indexed citations

13.

Aukema, Sietse, Eva Hoster, Andreas Rosenwald, et al.. (2017). Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood. 131(4). 417–420. 81 indexed citations

14.

Schmidt, J, Irina Bonzheim, Julia Steinhilber, et al.. (2017). EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK− anaplastic large-cell lymphoma. Laboratory Investigation. 97(9). 1095–1102. 13 indexed citations

15.

Szczepanowski, Monika, J. Lange, Christian Köhler, et al.. (2017). Cell‐of‐origin classification by gene expression and MYC‐rearrangements in diffuse large B‐cell lymphoma of children and adolescents. British Journal of Haematology. 179(1). 116–119. 12 indexed citations

16.

Hartmann, Sylvia, Dennis A. Eichenauer, Annette Plütschow, et al.. (2013). The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 122(26). 4246–4252. 112 indexed citations

17.

Tiacci, Enrico, Claudia Döring, Verena Brune, et al.. (2012). Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. Blood. 120(23). 4609–4620. 97 indexed citations

18.

Lamant, Laurence, Keith McCarthy, Emanuele S. G. d'Amore, et al.. (2011). Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study. Journal of Clinical Oncology. 29(35). 4669–4676. 98 indexed citations

19.

Hartmann, Elena, Verónica Fernández, Vı́ctor Moreno, et al.. (2008). Five-Gene Model to Predict Survival in Mantle-Cell Lymphoma Using Frozen or Formalin-Fixed, Paraffin-Embedded Tissue. Journal of Clinical Oncology. 26(30). 4966–4972. 85 indexed citations

20.

Oschlies, Ilske, Wolfram Klapper, Martin Zimmermann, et al.. (2006). Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood. 107(10). 4047–4052. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact